Limited preanalytical requirements for insulin measurement

Michael Vogeser1, Klaus G Parhofer

  • 1Institute of Clinical Chemistry, Hospital of the University of Munich, Marchioninistrasse 15, D-81377 Munich, Germany. Michael.Vogeser@med.uni-muenchen.de

Insights

Insulin remains stable in blood samples for 24 hours at room temperature when collected in EDTA tubes. This stability simplifies sample transport for insulin testing, making it more accessible for clinical use.

Area of Science:

  • Clinical Chemistry
  • Endocrinology
  • Laboratory Medicine

Background:

  • Accurate insulin measurement is crucial for diagnosing and managing metabolic disorders.
  • Sample stability during transport from clinics to labs impacts test reliability.
  • Current protocols often require immediate processing or freezing, posing logistical challenges.

Purpose of the Study:

  • To assess the stability of insulin in serum and plasma samples during transport.
  • To determine optimal storage conditions for maintaining insulin integrity.
  • To evaluate the influence of anticoagulants like EDTA and sodium fluoride on insulin stability.

Main Methods:

  • Blood samples were collected from 15 volunteers.
  • Samples were stored at room temperature for 24 hours, with and without additives (EDTA, sodium fluoride).
  • Insulin concentrations were measured and compared between different storage and additive conditions.

Main Results:

  • Insulin demonstrated stability in EDTA-containing tubes at room temperature for at least 24 hours.
  • Significantly lower insulin concentrations were observed in samples without additives or with potassium fluoride.
  • EDTA effectively preserved insulin integrity during simulated transport conditions.

Conclusions:

  • Insulin measurements are reliable when samples are transported within 24 hours at room temperature in EDTA tubes.
  • Centrifugation and freezing of plasma are unnecessary if samples are processed within 24 hours.
  • These findings support broader implementation of insulin testing for assessing insulin sensitivity.
Abstract

Related Concept Videos

Insulin Formulations: Types and Delivery01:27

Insulin Formulations: Types and Delivery

Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into rapid-acting...
Insulin: Biosynthesis, Chemistry, and Preparation01:25

Insulin: Biosynthesis, Chemistry, and Preparation

The endoplasmic reticulum (ER) of pancreatic β-cells synthesizes preproinsulin, which consists of a signal peptide, A and B chains, and a C-peptide. Preproinsulin is then cleaved and folded into proinsulin, which translocates to the Golgi apparatus for sorting and packaging into secretory granules. In these granules, enzymatic clipping generates insulin and C-peptide.
Damage or functional impairment of β-cells inhibits insulin production, leading to diabetes. Diabetes treatment primarily uses...
Insulin: Dosing Regimen and Adverse Effects01:16

Insulin: Dosing Regimen and Adverse Effects

Insulin-replacement therapy usually includes both long-acting insulin (basal) and short-acting insulin (to cater to postprandial needs). In a diverse group of type 1 diabetes patients, the average daily insulin dose is typically 0.5-0.7 units/kg body weight. However, obese patients and pubertal adolescents may need more due to insulin resistance.
The basal dose constitutes about 40%-50% of the total daily dose, with the rest as premeal insulin. The mealtime insulin dose should mirror...